Elevated Level of Imipenem-Resistant Gram-Negative Bacteria Isolated from Patients Attending Health Centers in North Gondar, Ethiopia

References

• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi:10.1016/S1473-3099(18)30605-430409683
   PubMed Web of Science ®Google Scholar
• U.S. Centers for Disease Control and Prevention. About Antimicrobial Resistance - Biggest Threats and Data 2019 AR Threats Report. Centers Dis Control Prev. 2019:125.
   Google Scholar
• World Bank Group. Drug-Resistant Infections: A Threat to Our Economic Future. World Bank Report.; 2017.
   Google Scholar
• Founou RC, Founou LL, Essack SY, Butaye P. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS One. 2017;12(12):12. doi:10.1371/journal.pone.0189621
   Web of Science ®Google Scholar
• Guitor AK, Wright GD. Antimicrobial Resistance and Respiratory Infections. Chest. 2018;154(5):1202–1212. doi:10.1016/j.chest.2018.06.01929959904
   PubMed Web of Science ®Google Scholar
• Ahmed SMA-Z, Abdelrahman SS, Saad DM, Osman IS, Osman MG, Khalil EAG. Etiological Trends and Patterns of Antimicrobial Resistance in Respiratory Infections. Open Microbiol J. 2018;12(1):34–40. doi:10.2174/187428580181201003429785214
   PubMedGoogle Scholar
• Beyene G, Regasa B, Yilma D, Sewunet T. Antimicrobial susceptibility pattern of bacterial isolates from community-acquired pneumonia patients in Jimma University Specialized Hospital, Jimma, Ethiopia. Saudi J Health Sci. 2015;4(1):59. doi:10.4103/2278-0521.151411
   Google Scholar
• Temesgen D, Bereded F, Derbie A, Biadglegne F. Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot Referral Hospital, Northwest Ethiopia: A cross-sectional study. Antimicrob Resist Infect Control. 2019;8(1):101. doi:10.1186/s13756-019-0560-031223478
   PubMed Web of Science ®Google Scholar
• Murray BE, Wood AJJ. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710–721. doi:10.1056/NEJM20000309342100710706902
   PubMed Web of Science ®Google Scholar
• Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother. 1994;38(3):547–557. doi:10.1128/AAC.38.3.5478203853
   PubMed Web of Science ®Google Scholar
• Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.28515903
   PubMed Web of Science ®Google Scholar
• Singh N, Manchanda V. Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources. Clin Microbiol Infect. 2017;23(4):216–218. doi:10.1016/j.cmi.2017.02.03428274769
   PubMed Web of Science ®Google Scholar
• Humphries RM, Ambler J, Mitchell SL, et al. CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol. 2018;56(4):e01934–17.29367292
   PubMed Web of Science ®Google Scholar
• Odds F. Biochemical Tests for Identification of Medical Bacteria. J Clin Pathol. 1981;34(5):572. doi:10.1136/jcp.34.5.572-a
   Google Scholar
• Amoli RI, Nowroozi J, Sabokbar A, Rajabniya R. Isolation of Stenotrophomonas maltophilia from clinical samples: an investigation of patterns motility and production of melanin pigment. Asian Pac J Trop Biomed. 2017;7(9):826–830. doi:10.1016/j.apjtb.2017.08.012
   Web of Science ®Google Scholar
• Thomas R, Hamat RA, Neela V. Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates. Virulence. 2014;5(2):326–330. doi:10.4161/viru.2772424448556
   PubMed Web of Science ®Google Scholar
• Welker E, Domfeh Y, Tyagi D, Sinha S, Fisher N. Genetic Manipulation of Stenotrophomonas maltophilia. Curr Protoc Microbiol. 2015;37(1):6F.2.1–6F.2.14. doi:10.1002/9780471729259.mc06f02s37
   Google Scholar
• Juretschko S, Timmermann G, Schmid M, et al. Combined molecular and conventional analyses of nitrifying bacterium diversity in activated sludge: Nitrosococcus mobilis and Nitrospira-like bacteria as dominant populations. Appl Environ Microbiol. 1998;64(8):3042–3051. doi:10.1128/AEM.64.8.3042-3051.19989687471
   PubMed Web of Science ®Google Scholar
• Heuer H, Krsek M, Baker P, Smalla K, Wellington EMH. Analysis of actinomycete communities by specific amplification of genes encoding 16S rRNA and gel-electrophoretic separation in denaturing gradients.. Appl Environ Microbiol. 1997;63(8):3233–3241. doi:10.1128/AEM.63.8.3233-3241.19979251210
   PubMed Web of Science ®Google Scholar
• Allers E, Niesner C, Wild C, Pernthaler J. Microbes enriched in seawater after addition of coral mucus. Appl Environ Microbiol. 2008;74(10):3274–3278. doi:10.1128/AEM.01870-0718344335
   PubMed Web of Science ®Google Scholar
• Pompilio A, Crocetta V, De Nicola S, Verginelli F, Fiscarelli E, Di Bonaventura G. Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. Front Microbiol. 2015;6:951.26441885
   PubMed Web of Science ®Google Scholar
• Azene MK, Beyene BA. Bacteriology and antibiogram of pathogens from wound infections at Dessie Laboratory, North East Ethiopia. Tanzan J Health Res. 2011;13(4):68–74. doi:10.4314/thrb.v13i4.6490126592050
   PubMedGoogle Scholar
• Mohammed A, Seid ME, Gebrecherkos T, Tiruneh M, Moges F. Bacterial Isolates and Their Antimicrobial Susceptibility Patterns of Wound Infections among Inpatients and Outpatients Attending the University of Gondar Referral Hospital, Northwest Ethiopia. Int J Microbiol. 2017;2017:8953829. doi:10.1155/2017/895382928386280
   PubMedGoogle Scholar
• Muluye D, Wondimeneh Y, Ferede G, et al. Bacterial isolates and their antibiotic susceptibility patterns among patients with pus and/or wound discharge at Gondar University hospital. BMC Res Notes. 2014;7(1):619. doi:10.1186/1756-0500-7-61925201246
   PubMedGoogle Scholar
• Nathan AM, Teh CSJ, Jabar KA, et al. Bacterial pneumonia and its associated factors in children from a developing country: A prospective cohort study. PLoS One. 2020;15(2):e0228056. doi:10.1371/journal.pone.022805632059033
   PubMed Web of Science ®Google Scholar
• Seboxa T, Amogne W, Abebe W, et al. High mortality from blood stream infection in Addis Ababa, Ethiopia, is due to antimicrobial resistance. PLoS One. 2015;10(12):e0144944. doi:10.1371/journal.pone.014494426670718
   PubMed Web of Science ®Google Scholar
• Troillet N, Samore MH, Carmeli CY. Imipenem-Resistant Pseudomonas Risk Factors and Antibiotic Susceptibility Patterns. Clin Infect Dis. 1997;25(5):1094–1098. doi:10.1086/5160929402364
   PubMed Web of Science ®Google Scholar
• Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010;14(3):R113. doi:10.1186/cc906220546564
   PubMed Web of Science ®Google Scholar
• Armand-Lefèvre L, Angebault C, Barbier F, et al. Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013;57(3):1488–1495. doi:10.1128/AAC.01823-1223318796
   PubMed Web of Science ®Google Scholar
• Ssekatawa K, Byarugaba DK, Wampande E, Ejobi F. A systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes. 2018;11(1):629. doi:10.1186/s13104-018-3738-230170613
   PubMedGoogle Scholar
• Agyepong N, Govinden U, Owusu-Ofori A, Essack SY. Multidrug-resistant Gram-negative bacterial infections in a teaching hospital in Ghana. Antimicrob Resist Infect Control. 2018;7(1):37. doi:10.1186/s13756-018-0324-229541448
   PubMed Web of Science ®Google Scholar
• Legese MH, Weldearegay GM, Asrat D Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children. Infect Drug Resist. 2017;10:27–34. doi:10.2147/IDR.S12717728182124
   PubMed Web of Science ®Google Scholar
• Codjoe F, Donkor E. Carbapenem Resistance: A Review. Med Sci. 2017;6(1):1.
   Google Scholar
• Khorshidi A, Sharif AR. Imipenem resistance among Gram-negative and Gram-positive bacteria in hospitalized patients. Iran J Public Health. 2010;39(2):110–113.23113015
   PubMed Web of Science ®Google Scholar
• Woodford N, Xu-McCrae L, Mushtaq S, et al. Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK). J Antimicrob Chemother. 2018;73(3):698–702. doi:10.1093/jac/dkx47129253163
   PubMed Web of Science ®Google Scholar
• Beyene D, Bitew A, Fantew S, Mihret A, Evans M, Ruiz-Rodriguez M. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911. doi:10.1371/journal.pone.022291131553773
   PubMed Web of Science ®Google Scholar
• Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3(1):15–21.26862399
   PubMed Web of Science ®Google Scholar
• Tängdén T, Giske CG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med. 2015;277(5):501–512. doi:10.1111/joim.1234225556628
   PubMed Web of Science ®Google Scholar
• Crossman LC, Gould VC, Dow JM, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;9(4):R74. doi:10.1186/gb-2008-9-4-r7418419807
   PubMed Web of Science ®Google Scholar
• Chusri S, Chongsuvivatwong V, Rivera JI, et al. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob Agents Chemother. 2014;58(7):4172–4179. doi:10.1128/AAC.02992-1424820079
   PubMed Web of Science ®Google Scholar